New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 20, 2019 - Teva launched an AB-rated generic version of Lundbeck’s Sabril (vigabatrin) tablets.
Download PDF
Return to publications
